Your search history is turned on.
Date: May 3, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
SAM SAMPLE 123 SAMPLES STREET SAMPLETOWN SS X9X X9X CANADA MPHQ MEDICURE INC. Security Class COMMON Holder Account Number C9999999999 IND Form of Proxy - Annual Meeting to be held on Tuesday, May 28, 2024 This Form of Proxy is solicited by and on behalf of Management. Notes to proxy 1. Every holder has the right to appoint some other pers...
Microsoft Word - Info Circular - April 2024 MEDICURE INC. MANAGEMENT PROXY CIRCULAR and NOTICE OF ANNUAL MEETING April 12, 2024 MEDICURE INC. 2-1250 Waverley Street Winnipeg, Manitoba R3T 6C6 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS NOTICE is hereby g...
Microsoft Word - Notice of Meeting - April 2024 MEDICURE INC. 2-1250 Waverley Street Winnipeg, Manitoba R3T 6C6 NOTICE OF ANNUAL MEETING OF SHAREHOLDERS NOTICE is hereby given that the annual meeting (the Meeting) of the shareholders of Medicure Inc. (the Corporation) will be held in Winnipeg, Manitoba, at 2-1250 Waverley Street, on Tuesday, May 28, 2...
Date: April 23, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
1 2-1250 Waverley Street Winnipeg, Manitoba, Canada R3T 6C6 Phone: 204-487-7412 Fax: 204-488-9823 MEDICURE RECEIVES US FDA FAST TRACK DESIGNATION FOR MC-1 FOR PNPO DEFICIENCY WINNIPEG, CANADA (April 23, 2024) Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a company focused on the development and commercialization of pharm...
Date: April 19, 2024 Jurisdictions: All jurisdictions
March 18, 2024 324-8th Avenue SW, 8th floor Calgary AB, T2P 2Z2 www.computershare.com To: All Canadian Securities Regulatory Authorities Subject: MEDICURE INC Dear Sir/Madam: We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual Meeting Record...
Date: April 8, 2024 Jurisdictions: Alberta, British Columbia, Manitoba, New Brunswick, All Jurisdictions, Nova Scotia, Ontario, Price Edward Island, Quebec, Saskatchewan
MEDICURE INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 or ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2023 or TRANSITION REPORT PURSUANT TO SEC...
Date: April 8, 2024 Jurisdictions: Alberta, Ontario
Create participation fee form FORM 13-502F1 CLASS 1 AND CLASS 3B REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, UDDIN, Haaris, an officer of the reporting issuer noted below have examined this Form 13-502F1 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonable...
Create participation fee form Note: [01 Mar 2017] The following is a consolidation of 13-501F1. It incorporates amendments to this document that came into effect on March 1, 2017. This consolidation is provided for your convenience and should not be relied on as authoritative. FORM 13-501F1 CLASS 1 REPORTING ISSUERS AND CLASS 3B REPORTING ISSUERS PARTICIPATI...
1 2-1250 Waverley Street Winnipeg, Manitoba, Canada R3T 6C6 Phone: 204-487-7412 Fax: 204-488-9823 MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER AND YEAR ENDED DECEMBER 31, 2023 WINNIPEG, CANADA (April 8, 2024) Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a company focused on the development and commercialization of pha...
Consolidated Financial Statements (Expressed in thousands of Canadian dollars, except per share amounts) MEDICURE INC. Year ended December 31, 2023 MANAGEMENT REPORT The accompanying consolidated financial statements have been prepared by management and approved by the Board of Directors of Medicure In...